A DNA Vaccine Targeting the Fetal Liver Kinase-1 (Flk-1) can Activate the Special CD8+ T Cell and Inhibit the Metastasis of Orthotopic Lewis Lung Cancer Model
- Authors
-
-
Xin Liu
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Yan Chen
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Zhi Ping Wu
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Cong Guo Jin
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Xiao Qun Chen
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Jia Li
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Yong Chun Zhou
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China -
Xi Cai Wang
Tumor Institute of Yunnan Province, the Third Affiliated Hospital of Kunming Medical University (Tumor Hospital of Yunnan Province), 519 Kunzhou Road, Kunming, Yunnan Province, 650118, P.R., China
-
- Keywords:
- Lung cancer, VEGFR-2, oral vaccine, angiogenesis, metastasis, orthotopic.
- Abstract
-
Lung cancer is the leading cause of cancer related deaths and need new more effective therapies. In this study, we investigated the anti-tumor effect of recombinant orally DNA vaccine delivered by attenuated S.typhimurium strain SL3261 (aroA mutant) targeting vascular endothelial growth factor receptor (VEGFR-2), also known as fetal liver kinase-1 (Flk-1) in mouse. The cDNA of extracellular domains (ECD) of VEGFR-2 (Flk-1ECD) was amplified by RT-PCR and cloned into the pcDNA3.1 (+) vector, then transformed to the attenuated S.typhimurium strain to construct the oral DNA vaccine. Then pcDNA3.1-Flk-1ECD was successfully transfected into COS-7 cells and the recombinant protein was detected by Western blot. The effect of the oral DNA vaccine was analyzed by flow cytometry (FCM) analysis and cytotoxicity assay. For mimic the local and regional growth pattern seen in lung cancer patients, the effect of the oral DNA vaccine on tumor growth and metastasis was analyzed by orthotopic cancer cells challenge in vivo. The results demonstrated that the oral DNA vaccine can overcome peripheral immune tolerance, and generated Flk-1- specific CD8+ cytotoxic T cell response. Moreover, this oral DNA vaccine could effectively reduce tumor growth, metastasis and increase the survival. It indicated that the oral VEGFR2 DNA vaccine encoding Flk-1ECD delivered by salmonella might act a potential strategy for immunotherapy of lung cancers.
- References
-
Jemal A, Siegel R, Ward E.CA Cancer J Clin 2009; 59: 225-49. http://dx.doi.org/10.3322/caac.20006
Carney DN.N Engl J Med 2002; 346: 126-8. PMID:11071679.
Herbst RS, Fidler IJ. Clin Cancer Res 2000; 6: 4604-6. PMID:11156208.
Cox G, Jones JL, Walker RA.Lung Cancer 2000; 27 : 81-100. PMID:10688491. http://dx.doi.org/10.1016/S0169-5002(99)00096-3
Marrogi AJ, Travis WD, Welsh JA.Clin Cancer Res2000; 6: 4739-44. PMID:11156228.
Fontanini G, Boldrini L, Chinè S. Br J Cancer 1999; 79: 363-9. http://dx.doi.org/10.1038/sj.bjc.6690058
Giatromanolaki A, Koukourakis MI, Kakolyris S. Clin Cancer Res 1998; 4: 3017-24. PMID:9865915.
Cross MJ, Claesson-Welsh L.Trends Pharmacol Sci 2001; 22: 201-207. PMID:11282421. http://dx.doi.org/10.1016/S0165-6147(00)01676-X
Lee SH, Mizutani N, Mizutani M.Endoglin.Cancer Immunol Immunother 2006; 55: 1565-74. http://dx.doi.org/10.1007/s00262-006-0155-5
Felicetti P, Mennecozzi M, Barucca A. Cytotherapy 2007; 9: 23-34. http://dx.doi.org/10.1080/14653240601048369
Jiao JG, Li YN, Wang H. Dig Liver Dis 2006; 38: 578-87. http://dx.doi.org/10.1016/j.dld.2006.04.014
Holmgren L, Ambrosino E, Birot O. Proc Natl Acad Sci USA 2006; 103: 9208- 9213. http://dx.doi.org/10.1073/pnas.0603110103
Bauer H, Darji A, Chakraborty T. Gene Ther 2005; 12: 364-72. http://dx.doi.org/10.1038/sj.gt.3302423
Weiss S,Chakraborty T. Curr Opin Biotechnol 2001; 12: 467-72. PMID:11604322. http://dx.doi.org/10.1016/S0958-1669(00)00247-0
Vassaux G, Nitcheu J, Jezzard S. J Pathol 2006; 208: 290-8. http://dx.doi.org/10.1002/path.1865
Yazawa K, Fujimori M, Nakamura T. Breast Cancer Res Treat 2001; 66: 165-170. http://dx.doi.org/10.1023/A:1010644217648
Agorio C, Schreiber F, Sheppard M. J Gene Med 2007; 9: 416-23. http://dx.doi.org/10.1002/jgm.1023
Ruan Z, Yang Z, Wang Y.J Immunother 2009; 32: 486-91. http://dx.doi.org/10.1097/CJI.0b013e3181a1d134
Luo Y, Markowitz D, Xiang R. Vaccine 2007; 25: 1409-15. http://dx.doi.org/10.1016/j.vaccine.2006.10.043
Zuo SG, Chen Y, Wu ZP. Biol Pharm Bull 2010; 33: 174-82. http://dx.doi.org/10.1248/bpb.33.174
Onn A, Isobe T, Itasaka S. Clin Cancer Res 2003; 9: 5532-9. PMID:14654533.
MacLachlan PR, Sanderson KE. J Bacteriol 1985; 161: 442-5. PMID:3881397.
Li Y, Wang MN, Li H.J Exp Med 2002,195: 1575-84. http://dx.doi.org/10.1084/jem.20020072
Paterson Y, Guirnalda PD,Wood LM.Semin Immunol 2010; 22: 183-9. http://dx.doi.org/10.1016/j.smim.2010.02.002
Moreno M, Kramer MG, Yim L.Curr Gene Ther 2010; 10: 56-76. http://dx.doi.org/10.2174/156652310790945566
Gentschev I, Fensterle J, Schmidt A. BMC Cancer 2005,9: 15. http://dx.doi.org/10.1186/1471-2407-5-15
Dong J, Yang J, Chen MQ. Cancer Biol Ther 2008; 7: 502-9. http://dx.doi.org/10.4161/cbt.7.4.5477
Vazquez-Torres A, Jones-Carson J, Baumler AJ. Nature 1999; 401(6755): 804- 808. http://dx.doi.org/10.1038/44593
Dunlap NE, Benjamin WH. Immunol Ser 1994; 60: 303-12. PMID:8251577.
Peters C, Paterson Y. Vaccine 2003; 21: 1187-1194. PMID:12559797. http://dx.doi.org/10.1016/S0264-410X(02)00554-6
Folkman J. Nat Med 1996; 2: 167-8. PMID:8574960.
Zhu Z, Hattori K, Zhang H. Leukemia 2003; 17: 604-11. http://dx.doi.org/10.1038/sj.leu.2402831
Brekken RA, Overholser JP, Stastny VA.Cancer Res 2000; 60: 5117-24. PMID:11016638
Zhou H, Luo Y, Mizutani M.Blood 2005; 106: 2026-32. http://dx.doi.org/10.1182/blood-2005-03-0969
Banchereau J,Steinman RM. Nature 1998; 392: 245-52. http://dx.doi.org/10.1038/32588
Paget S.Cancer Metastasis Rev 1989; 8: 98-101. PMID:2673568
- Downloads
- Published
- 2013-12-28
- Issue
- Vol. 2 No. 4 (2013)
- Section
- Articles
How to Cite
Similar Articles
- Anshika N. Singh, Neeti Sharma, In silico Meta-Analysis of Circulatory microRNAs in Prostate Cancer , Journal of Analytical Oncology: Vol. 6 No. 2 (2017)
- K.J. N'Dah, E. Troh, B. Doukouré, K.E. Koffi, M. Kouyaté, B.S. Koui, N.A. Aman, A.D. Abouna, K.D. Koffi, B. Traoré, A.B. Effi, M.I.J.M. Diomandé, Epidemiological and Pathological Aspects of Cervical Cancer in Ivory Coast , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Jose Manuel Ornelas-Aguirre, Laura Maria de la Asunción Perez-Michel, Immunohistochemical Profile and Clinical-Pathological Variants of Breast Cancer in Northeastern Mexico , Journal of Analytical Oncology: Vol. 2 No. 2 (2013)
- Joseph E. Udosen, John A. Ashindoitiang, Victor I.C. Nwagbara, Theophilus I. Ugbem, Joseph S. Ukam, Maurice E. Asuquo, Concurrent Plasma Cell Mastitis and Metastatic Breast Cancer a Rare Presentation of a Bilateral Disease: Case Report and Literature Review , Journal of Analytical Oncology: Vol. 13 (2024)
- Ravoori Harish Babu, Amritha Prabha Shankar, Geeta S. Narayanan, Ganesh M. Subramanya, B.R. Kiran Kumar, Association of Level III Axillary Lymph Node Positivity with Clinicopathological Characteristics in Breast Cancer , Journal of Analytical Oncology: Vol. 13 (2024)
- A. Leskanicova, P. Simko, N. Zidekova, M. Babincak, A. Blicharova, M. Kertys, J. Kostolný, D. Maceková, T. Kiskova, Chemically Induced Brain Cancer in Sprague-Dawley Rats: Changed Lipidomics Mimics the Human Conditions , Journal of Analytical Oncology: Vol. 13 (2024)
- Tchin Darré, Haréfétéguéna Bissa, Komlavi Ehlissou Akloa, Essobozou Pegbessou, Bathokédeou Amana, Aman Alphonse N’guessan, Koffi Amégbor, Essohana Boko , Gado Napo-Koura, Epidemiological and Pathological Aspects of Head and Neck Cancers in Togo , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Omar Youssef, Virinder Kaur Sarhadi, Lauri Lehtimäki, Milja Tikkanen, Arto Kokkola, Pauli Puolakkainen, Gemma Armengol, Sakari Knuutila, Peritoneal Carcinomatosis and Multi-Organ Metastases are Prognostic Factors in Colorectal Cancer: A Retrospective Analysis , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Charles E. Myers, Neuroendocrine Differentiation and Epithelial to Mesenchymal Transition in Prostate Cancer: cAMP-Dependent Signaling as a Therapeutic Target , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Vu Hong Thang, Lambert Skoog, Nguyen Ba Duc, Ta Thanh Van, Edneia Tani , Cell Proliferation Measured by Ki67 Staining and Correlation to Clinicopathological Parameters in Operable Breast Carcinomas from Vietnamese and Swedish Patients , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
You may also start an advanced similarity search for this article.